You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
|No Recent Quote currently available|
My Portfolio Tracker
One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.
Dec 28, 2012 (SmarTrend(R) News Watch via COMTEX) -- Shares of Merck (NYSE:MRK) opened today below their pivot of $41.14 and have already reached the first level of support at $40.86. Investors may be interested in a cross of the next downside pivot targets of $40.53 and $39.92.
In the past 52 weeks, shares of Merck have traded between a low of $36.91 and a high of $48.00 and are now at $40.91, which is 11% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.6%.
There is potential upside of 21.2% for shares of Merck based on a current price of $40.91 and an average consensus analyst price target of $49.56. Merck shares should first meet resistance at the 200-day moving average (MA) of $41.99 and find additional resistance at the 50-day MA of $44.51.
SmarTrend is monitoring the recent change of momentum in Merck. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Merck in search of a potential trend change.
Write to Chip Brian at firstname.lastname@example.org
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
Copyright, Comtex News Network, Inc. 2012
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Copyright 2014 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.